ChemicalBook > Product Catalog >API >Antibiotics >Other antibiotic Drugs >Oseltamivir phosphate

Oseltamivir phosphate

Oseltamivir phosphate Structure
CAS No.
204255-11-8
Chemical Name:
Oseltamivir phosphate
Synonyms
Osteltamivir phosphate;Oseltamivir Phosphate (200 mg);(3R,5S)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate;(3R,4R,5S)-ethyl 4-acetaMido-5-aMino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate;SOT;Oselt;CS-1978;Oseltamivir PH;Ostavir phosphate;US-DMF No.: 035876
CBNumber:
CB2119221
Molecular Formula:
C16H31N2O8P
Molecular Weight:
410.4
MOL File:
204255-11-8.mol
MSDS File:
SDS
Modify Date:
2024/6/24 22:20:23

Oseltamivir phosphate Properties

Melting point 196-198°C
storage temp. 2-8°C
solubility H2O: soluble30mg/mL, clear
form powder
color white to beige
optical activity [α]/D -26 to -36°, c = 1 in H2O
Water Solubility Soluble in water (75 mM)
BCS Class 1 (CLogP), 3 (LogP)
InChI InChI=1/C16H28N2O4.H3O4P/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19;1-5(2,3)4/h9,12-15H,5-8,17H2,1-4H3,(H,18,19);(H3,1,2,3,4)/t13-,14+,15+;/s3
InChIKey PGZUMBJQJWIWGJ-IFAKAUOZSA-N
SMILES [C@@H]1(OC(CC)CC)C=C(C[C@H](N)[C@H]1NC(=O)C)C(=O)OCC.OP(O)(O)=O |&1:0,10,12,r|
CAS DataBase Reference 204255-11-8(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H317-H319-H412
Precautionary statements  P261-P264-P273-P280-P302+P352-P305+P351+P338
HazardClass  IRRITANT
HS Code  2924299500
NFPA 704
0
2 0

Oseltamivir phosphate price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) SML1606 Oseltamivir phosphate ≥98% (HPLC) 204255-11-8 100MG ₹8486.8 2022-06-14 Buy
Sigma-Aldrich(India) PHR1781 Oseltamivir Phosphate Pharmaceutical Secondary Standard; Certified Reference Material 204255-11-8 500MG ₹16215.85 2022-06-14 Buy
Product number Packaging Price Buy
SML1606 100MG ₹8486.8 Buy
PHR1781 500MG ₹16215.85 Buy

Oseltamivir phosphate Chemical Properties,Uses,Production

Description

Oseltamivir phosphate (Tamiflu) was launched in the US and Switzerland for the treatment of influenza infections by all common strain viruses. It is an oral anti-viral drug approved for the treatment of acute, uncomplicated influenza in patients 2 weeks of age and older whose flu symptoms have not lasted more than two days. This product is approved to treat Type A and B influenza; however, the majority of patients included in the studies were infected with type A, the most common in the U.S. Efficacy of Tamiflu in the treatment of influenza in subjects with chronic cardiac disease and/or respiratory disease has not been established.

Chemical Properties

White Cyrstalline Solid. It is freely soluble in water.

Uses

Oseltamivir phosphate (Tamiflu) is a competitive neuraminidase inhibitor. The prodrug oseltamivir phosphate (Tamiflu) is itself not virally effective; however, once in the liver, it is converted by natural chemical processes, hydrolysed hepatically to its

Definition

ChEBI: Oseltamivir phosphate is a phosphate salt. It contains an oseltamivir. It is an acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.

Preparation

Oseltamivir phosphate (Tamiflu) has been synthesized from cis-2,3-bis(hydroxymethyl)aziridine. After protection of the cis-2,3-bis(hydroxymethyl)aziridine with a Boc group, desymmetrization provided a chiral aziridine, which was a key intermediate to install the required stereogenic center containing a nitrogen atom. Allylation and ring closing metathesis are the key reactions to obtain the cyclic product that was successfully converted to the desired oseltamivir phosphate. DOI: 10.1021/jo3015853
synthesis of Oseltamivir phosphate
It can also be obtained by a novel 12-step synthesis from (-)-quinic acid.

General Description

receptor site showed clearly that additional binding sitesexist for the C-5 acetamido carbonyl group and the arginineresidue at position 152 of the receptor site. In addition, the C-2 carboxyl group of sialic acid binds to Arg 118, Arg 292, andArg 371. Position C-6 is capable of undergoing a hydrophobicinteraction with various amino acids, including Glu, Ala,Arg, and Ile. Maximum binding to neuraminidase occurswhen the C-6 substituent is substituted with a nonpolar chain.In oseltamivir, this nonpolar group is 3-pentyl. An importantfeature of oseltamivir is the ethyl ester, which makes the drugorally efficacious. This drug is the first orally active agent foruse against influenza A and B. It is also indicated for the treatmentof acute illness. If administered within 2 days after theonset of influenza symptoms, the drug is effective.

Clinical Use

Oseltamivir was approved as the first orally administered neuraminidase inhibitor used against influenza A and B viruses. The drug is indicated for the treatment of uncomplicated acute illness caused by influenza infection.

Side effects

Side effects with oseltamivir are minor, consist of nausea and vomiting, and occur primarily in the first two days of therapy.

Metabolism

Oseltamivir is readily absorbed from the GI tract following oral administration. It is a prodrug that is extensively metabolized in the liver, undergoing ester hydrolysis to the active carboxylic acid. Two oxidative metabolites also have been isolated, with the major oxidation product being the ω-carboxylic acid.

Mode of action

Oseltamivir Phosphate is the phosphate salt of oseltamivir, a synthetic derivative prodrug of ethyl ester with antiviral activity. By blocking neuraminidases on the surfaces of influenza viruses, oseltamivir interferes with host cell release of complete viral particles.

Oseltamivir phosphate Preparation Products And Raw materials

Global( 578)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
SGMR PHARMACEUTICALS PVT LTD +91-9032001889 +91-9032001889 Telangana, India 83 58 Inquiry
SEUTIC +91-8309787199 +91-8309787199 Hyderabad, India 124 58 Inquiry
CDYMAX +91-9019317788 +91-9019317788 Bangalore, India 28 58 Inquiry
Gonane Pharma +91-9819380043 +91-9819380043 NaviMumbai, India 192 58 Inquiry
Lupin Ltd +91-8019896181 +91-8019896181 Maharashtra, India 93 58 Inquiry
Cipla Ltd +912224826000 Maharashtra, India 133 58 Inquiry
Hetero Drugs Limited +91-4023704923 +91-4023704923 Telangana, India 296 58 Inquiry
Everest Organics Limited +91-4040028838 +91-9440409996 Hyderabad, India 61 58 Inquiry
Solara Active Pharma Sciences Ltd +91-8046632100 +91-7075706520 Bangalore, India 65 58 Inquiry
Zydus Lifesciences Ltd. +91-0265-2315243 +91-6358895661 Gujarat, India 89 58 Inquiry

Related articles

Oseltamivir phosphate Spectrum

Oseltamivir phosphat Oselt OseltaMivir Acid-D3 Phosphate OseltaMivir phosphate (TaMiflu) OseltaMir phosphate (3R,4R,5S)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)--cyclohexene-1-carboxylic acid ethyl ester, phosphate (1:1) Oseltamivir phosphate (impurity B free) Oseltamivir phosphate, >=98% Olstamivir Phosphate ethyl (3r,4r,5s)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate phosphate NTERMEDIATES OF OSELTAMIVIR OSELTAMIVIR PHOSPHATE (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester phosphate salt OSELTAMIVIR PHOSPHATE USP (GROUP:B SRL N O:1449 SOT Oseltamivir Phosphate Capsules CS-1978 Oseltamivir PH ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylate Oseltamivir phosphate (impurity B-free) CRS oseltamivir phsphate 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate (1:1) Oseltamivir phosphate USP/EP/BP Aseltamivir phosphate Oseltamivir phosphate-d5 (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester Oseltamivir phosphate (GS-4104) US-DMF No.: 035876 Oseltamivir PhosphateQ: What is Oseltamivir Phosphate Q: What is the CAS Number of Oseltamivir Phosphate Q: What is the storage condition of Oseltamivir Phosphate Q: What are the applications of Oseltamivir Phosphate Oseltamivir Phosphate (1479304) Osteltamivir phosphate (3R,5S)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate Oseltamivir Phosphate (200 mg) (3R,4R,5S)-ethyl 4-acetaMido-5-aMino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate Ethyl (3r,4r,5s)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate (-)-Oseltamivir phosphate (+)-N-Trifluoroacetyl-4-demethoxydaunorubicin phosphenoperoxoic acid compound with ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate and dihydrogen (1:1:1) Ostavir phosphate 204255-11-8 204255-11-9 204265-11-8 C16H28N2O4H3O4P C16H31N2O8P C16H28N2O4H3PO4 C16H27N2O4 API Tamiflu Amines Anti-virals apis Influenza Viruses Intermediates & Fine Chemicals Pharmaceuticals Ring Systems Oseltamivir 204255-11-8